Lack of cross-tolerance between haloperidol and clozapine towards Fos-protein induction in rat forebrain regions

European Journal of Pharmacology

Volumn 315, Issue 3, 1996, Pages 269-275

  Sebens, Jantiena B ^a   Koch, Tineke ^a   Korf, Jakob ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

Clozapine; Cross tolerance; Fos protein; Haloperidol; Nucleus accumbens; Septum, lateral

Indexed keywords

CLOZAPINE; HALOPERIDOL; NEUROLEPTIC AGENT;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN REGION; CONTROLLED STUDY; CROSS TOLERANCE; DRUG RESPONSE; FOREBRAIN; GENE EXPRESSION; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; NONHUMAN; NUCLEUS ACCUMBENS; ONCOGENE C FOS; PRIORITY JOURNAL; RAT;

ANIMALS; CLOZAPINE; DRUG INTERACTIONS; DRUG TOLERANCE; HALOPERIDOL; MALE; PROSENCEPHALON; PROTO-ONCOGENE PROTEINS C-FOS; RATS; RATS, WISTAR;

EID: 0030597317     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(96)00649-8     Document Type: Article

References (39)

1. Albinsson, A, T. Lundstedt and G. Andersson, 1993, Use of neuroendocrine effects in discrimination between CNS-active drugs in the rat, Drug Dev. Res. 29, 227.
2. Beckstead, R.M., V.B. Domesick and W.J.H. Nauta, 1979, Efferent connections of the substantia nigra and ventral tegmental area in the rat, Brain Res. 175, 191.
3. Bolden, C, B. Cusack and E. Richelson, 1991, Clozapine is a potent and selective muscarinic antagonist at the five cloned human muscarinic acetylcholine receptors expressed in CHO-K1 cells, Eur. J. Pharmacol. 192, 205.
4. 2 receptor mRNA, Brain Res. 564, 203.
5. 2 subtypes of dopamine receptors in rat brain, J. Neurosci. 6, 3177.
6. Coward, D.M., A. Imperato, S. Urwyler and T.G. White, 1989, Biochemical and behavioural properties of clozapine, Psychopharmacology 99, S6.
7. Deutch, A.Y., M.C. Lee and M.J. Iadarola, 1992, Regionally specific effects of atypical antipsychotic drugs on striatal Fos expression: the nucleus accumbens shell as a locus of antipsychotic action, Mol. Cell. Neurosci. 3, 332.
8. 2 dopamine receptor antagonists induce Fos and related proteins in rat striatal neurons, Neuroscience 37, 287.
9. 2 dopamine receptor occupancy in patients treated with classical neuroleptics and clozapine. Relation to extrapyramidal side effects, Arch. Gen. Psychiatry 49, 538.
10. 2-receptor occupancy in clozapine-treated patients, J. Clin. Psychiatry 55 (Suppl. B), 67.
11. Fink-Jensen, A. and P. Kristensen, 1994, Effects of typical and atypical neuroleptics on Fos protein expression in the rat forebrain, Neurosci. Lett. 182, 115.
12. Fuller, R.W., 1990, Serotonin receptors and neuroendocrine responses, Neuropsychopharmacology 3, 495.
13. Gudelsky, G.A., J.F. Nash, S.A. Berry and H.Y. Meltzer, 1989, Basic biology of clozapine: electrophysiological and neuroendocrinological studies, Psychopharmacology 99 (Suppl. P), S13.
14. Henderson, D.C. and D.C. Goff, 1994, Clozapine for polydipsia and hyponatremia in chronic schizophrenics, Biol. Psychiatry 36, 768.
15. Illowsky, B.P. and D.G. Kirch, 1988, Polydipsia and hyponatremia in psychiatric patients, Am. J. Psychiatry 145, 675.
16. Kane, J., G. Honigfeld, J. Singer and H. Meltzer, 1988, Clozapine for the treatment-resistant schizophrenic, Arch. Gen. Psychiatry 45, 789.
17. Kjaer, A., P.J. Larsen, U. Knigge, M. Moeller and J. Warberg, 1994, Histamine stimulates c-fos expression in hypothalamic vasopressin-, oxytocin-, and corticotropin-releasing hormone-containing neurons, Endocrinology 134, 482.
18. Kleinbaum, D.G., L.L. Kupper and K.E. Muller, 1988, Applied regression analysis and other multivariable methods (PWS-KENT, Boston, MA).
19. Leadbetter, R.A. and M.S. Shutty, Jr., 1994, Differential effects of neuroleptics and clozapine on polydipsia and intermittent hyponatremia, J. Clin. Psychiatry 55 (Suppl. B), 110.
20. Lee, H.S., K.Y. Kwon, L.D. Alphs and H.Y. Meltzer, 1991, Effect of clozapine on psychogenic polydipsia in chronic schizophrenia, J. Clin. Psychopharmacol. 11, 223.
21. 2 receptors in the rat striatal complex and its comparison with acetylcholinesterase, Brain Res. Bull. 22, 805.
22. MacGibbon, G.A., P.A. Lawlor, R. Bravo and M. Dragunow, 1994, Clozapine and haloperidol produce a differential pattern of immediate early gene expression in rat caudate-putamen, nucleus accumbens, lateral septum and islands of Calleja, Mol. Brain Res. 23, 21.
23. McGeorge, A.J. and R.L.M. Faull, 1989, The organisation of the projection from the cerebral cortex to the striatum in the rat, Neuroscience 29, 503.
24. Merchant, K.M., D.J. Dobie, F.M. Filloux, M. Totzke, M. Aravagiri and D.M. Dorsa, 1994, Effects of chronic haloperidol and clozapine treatment on neurotensin and c-fos mRNA in rat neostriatal subregions, J. Pharmacol. Exp. Ther. 271, 460.
25. Naber, D., R. Holzbach, C. Perro and H. Hippius, 1992, Clinical management of clozapine patients in relation to efficacy and side-effects, Br. J. Psychiatry 160 (Suppl. 17), 54.
26. Nash, J.F., H.Y. Meltzer and G.A. Gudelsky, 1988, Antagonism of serotonin receptor mediated neuroendocrine and temperature responses by atypical neuroleptics in the rat, Eur. J. Pharmacol. 151, 463.
27. Nguyen, T.V., B.E. Kosofsky, R. Birnbaum, B.M. Cohen and S.E. Hyman, 1992, Differential expression of c-Fos and Zif268 in rat striatum after haloperidol, clozapine, and amphetamine, Proc. Natl. Acad. Sci. USA 89, 4270.
28. Richelson, E., 1985, Pharmacology of neuroleptics in use in the United States, J. Clin. Psychiatry 46, 8.
29. Robertson, G.S. and H.C. Fibiger, 1992, Neuroleptics increase c-fos expression in the forebrain: contrasting effects of haloperidol and clozapine, Neuroscience 46, 315.
30. Robertson, G.S., H. Matsumura and H.C. Fibiger, 1994, Induction patterns of Fos-like immunoreactivity in the forebrain as predictors of atypical antipsychotic activity, J. Pharmacol. Exp. Ther. 271 (2), 1058.
31. Sebens, J.B., T. Koch, G.J. Ter Horst and J. Korf, 1995, Differential Fos-protein induction in rat forebrain regions after acute and long-term haloperidol and clozapine treatment, Eur. J. Pharmacol. 273, 175.
32. Sheng, M. and M.E. Greenberg, 1990, The regulation and function of c-fos and other immediate early genes in the nervous system, Neuron 4, 477.
33. 3) as a target for neuroleptics, Nature 347, 146.
34. 3) as a novel target for antipsychotics, Biochem. Pharmacol. 43, 659.
35. Todorova, A. and W. Dimpfel, 1994, Multiunit activity from the A9 and A10 areas in rats following chronic treatment with different neuroleptic drugs, Eur. Neuropsychopharmacol. 4, 491.
36. 4 receptor with high affinity for the antipsychotic clozapine, Nature 350, 610.
37. 4 receptor variants in the human population, Nature 358, 149.
38. Wan, W., D.J. Ennulat and B.M. Cohen, 1995, Acute administration of typical and atypical antipsychotic drugs induces distinctive patterns of Fos expression in the rat forebrain, Brain Res. 688, 95.
39. Zahn, T.P. and D. Pickar, 1993, Autonomic effects of clozapine in schizophrenia: comparison with placebo and fluphenazine, Biol. Psychiatry 34, 3.